Literature DB >> 10085245

Kinetic properties and tissular distribution of mammalian phosphomannomutase isozymes.

M Pirard1, Y Achouri, J F Collet, E Schollen, G Matthijs, E Van Schaftingen.   

Abstract

Human tissues contain two types of phosphomannomutase, PMM1 and PMM2. Mutations in the PMM2 gene are responsible for the most common form of carbohydrate-deficient glycoprotein syndrome [Matthijs, Schollen, Pardon, Veiga-da-Cunha, Jaeken, Cassiman and Van Schaftingen (1997) Nat. Genet. 19, 88-92]. The protein encoded by this gene has now been produced in Escherichia coli and purified to homogeneity, and its properties have been compared with those of recombinant human PMM1. PMM2 converts mannose 1-phosphate into mannose 6-phosphate about 20 times more rapidly than glucose 1-phosphate to glucose 6-phosphate, whereas PMM1 displays identical Vmax values with both substrates. The Ka values for both mannose 1,6-bisphosphate and glucose 1,6-bisphosphate are significantly lower in the case of PMM2 than in the case of PMM1. Like PMM1, PMM2 forms a phosphoenzyme with the chemical characteristics of an acyl-phosphate. PMM1 and PMM2 hydrolyse different hexose bisphosphates (glucose 1,6-bisphosphate, mannose 1,6-bisphosphate, fructose 1,6-bisphosphate) at maximal rates of approximately 3.5 and 0.3% of their PMM activity, respectively. Fructose 1,6-bisphosphate does not activate PMM2 but causes a time-dependent stimulation of PMM1 due to the progressive formation of mannose 1,6-bisphosphate from fructose 1,6-bisphosphate and mannose 1-phosphate. Experiments with specific antibodies, kinetic studies and Northern blots indicated that PMM2 is the only detectable isozyme in most rat tissues except brain and lung, where PMM1 accounts for about 66 and 13% of the total activities, respectively.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10085245      PMCID: PMC1220145     

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  36 in total

1.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.

Authors:  M M Bradford
Journal:  Anal Biochem       Date:  1976-05-07       Impact factor: 3.365

2.  Phosphomannomutase deficiency is the main cause of carbohydrate-deficient glycoprotein syndrome with type I isoelectrofocusing pattern of serum sialotransferrins.

Authors:  J Jaeken; J Artigas; R Barone; A Fiumara; T J de Koning; B T Poll-The; J F de Rijk-van Andel; G F Hoffmann; B Assmann; E Mayatepek; M Pineda; M A Vilaseca; J M Saudubray; B Schlüter; R Wevers; E Van Schaftingen
Journal:  J Inherit Metab Dis       Date:  1997-07       Impact factor: 4.982

3.  Comparison of PMM1 with the phosphomannomutases expressed in rat liver and in human cells.

Authors:  M Pirard; J F Collet; G Matthijs; E Van Schaftingen
Journal:  FEBS Lett       Date:  1997-07-14       Impact factor: 4.124

4.  A new class of phosphotransferases phosphorylated on an aspartate residue in an amino-terminal DXDX(T/V) motif.

Authors:  J F Collet; V Stroobant; M Pirard; G Delpierre; E Van Schaftingen
Journal:  J Biol Chem       Date:  1998-06-05       Impact factor: 5.157

Review 5.  Analytical luminescence: its potential in the clinical laboratory.

Authors:  T P Whitehead; L J Kricka; T J Carter; G H Thorpe
Journal:  Clin Chem       Date:  1979-09       Impact factor: 8.327

6.  Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications.

Authors:  H Towbin; T Staehelin; J Gordon
Journal:  Proc Natl Acad Sci U S A       Date:  1979-09       Impact factor: 11.205

7.  Ribonucleic acid isolated by cesium chloride centrifugation.

Authors:  V Glisin; R Crkvenjakov; C Byus
Journal:  Biochemistry       Date:  1974-06-04       Impact factor: 3.162

8.  A specific enzyme for glucose 1,6-bisphosphate synthesis.

Authors:  I A Rose; J V Warms; G Kaklij
Journal:  J Biol Chem       Date:  1975-05-10       Impact factor: 5.157

9.  Lack of homozygotes for the most frequent disease allele in carbohydrate-deficient glycoprotein syndrome type 1A.

Authors:  G Matthijs; E Schollen; E Van Schaftingen; J J Cassiman; J Jaeken
Journal:  Am J Hum Genet       Date:  1998-03       Impact factor: 11.025

10.  DNA sequencing with chain-terminating inhibitors.

Authors:  F Sanger; S Nicklen; A R Coulson
Journal:  Proc Natl Acad Sci U S A       Date:  1977-12       Impact factor: 11.205

View more
  24 in total

1.  From structure to function: YrbI from Haemophilus influenzae (HI1679) is a phosphatase.

Authors:  James F Parsons; Kap Lim; Aleksandra Tempczyk; Wojiech Krajewski; Edward Eisenstein; Osnat Herzberg
Journal:  Proteins       Date:  2002-03-01

2.  A deeply divergent phosphoglucomutase (PGM) of Giardia lamblia has both PGM and phosphomannomutase activities.

Authors:  Sanghamitra Mitra; Jike Cui; Phillips W Robbins; John Samuelson
Journal:  Glycobiology       Date:  2010-05-27       Impact factor: 4.313

3.  Protein inhibitor of activated STAT1 interacts with and up-regulates activities of the pro-proliferative transcription factor Krüppel-like factor 5.

Authors:  James X Du; C Chris Yun; Agnieszka Bialkowska; Vincent W Yang
Journal:  J Biol Chem       Date:  2006-12-18       Impact factor: 5.157

Review 4.  Structures of proteins of biomedical interest from the Center for Eukaryotic Structural Genomics.

Authors:  George N Phillips; Brian G Fox; John L Markley; Brian F Volkman; Euiyoung Bae; Eduard Bitto; Craig A Bingman; Ronnie O Frederick; Jason G McCoy; Betsy L Lytle; Brad S Pierce; Jikui Song; Simon N Twigger
Journal:  J Struct Funct Genomics       Date:  2007-09-06

5.  Ontogeny of D-mannose transport and metabolism in rat small intestine.

Authors:  Mecedes Cano; Anunciación A Ilundain
Journal:  J Membr Biol       Date:  2010-06-04       Impact factor: 1.843

6.  Glycosylation defects and virulence phenotypes of Leishmania mexicana phosphomannomutase and dolicholphosphate-mannose synthase gene deletion mutants.

Authors:  A Garami; A Mehlert; T Ilg
Journal:  Mol Cell Biol       Date:  2001-12       Impact factor: 4.272

7.  A phosphohexomutase from the archaeon Sulfolobus solfataricus is covalently modified by phosphorylation on serine.

Authors:  W Keith Ray; Sabrina M Keith; Andrea M DeSantis; Jeremy P Hunt; Timothy J Larson; Richard F Helm; Peter J Kennelly
Journal:  J Bacteriol       Date:  2005-06       Impact factor: 3.490

8.  DFT investigation on the reaction mechanism catalyzed by α-phosphomannomutase1 in protonated/deprotonated states.

Authors:  Hui-Ying Chu; Qing-Chuan Zheng; Xue Li; Yong-Shan Zhao; Ji-Long Zhang; Hong-Xing Zhang
Journal:  J Mol Model       Date:  2010-05-30       Impact factor: 1.810

Review 9.  Congenital disorders of glycosylation: review of their molecular bases, clinical presentations and specific therapies.

Authors:  T Marquardt; J Denecke
Journal:  Eur J Pediatr       Date:  2003-03-15       Impact factor: 3.183

10.  Mammalian phosphomannomutase PMM1 is the brain IMP-sensitive glucose-1,6-bisphosphatase.

Authors:  Maria Veiga-da-Cunha; Wendy Vleugels; Pushpa Maliekal; Gert Matthijs; Emile Van Schaftingen
Journal:  J Biol Chem       Date:  2008-10-16       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.